Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2020 | Apr. 06, 2021 | Jun. 30, 2020 | |
Document Information Line Items | |||
Entity Registrant Name | SCVX Corp. | ||
Document Type | 10-K/A | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Public Float | $ 229,100,000 | ||
Amendment Flag | true | ||
Amendment Description | References throughout this Amendment No. 2to the Annual Report on Form 10-K/A to “we,” “us,” the “Company” or “our company” are to SCVX Corp., unless the context otherwise indicates. This Amendment No. 2 (“Amendment No. 2”) to the Annual Report on Form 10-K/A amends the Annual Report on Form 10-K of SCVX Corp., for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on April 6, 2021 (the “Original Filing”). In preparation of the Company’s unaudited condensed financial statements as of and for quarterly period ended September 30, 2021, the Company concluded it should restate its financial statements to classify all Class A ordinary shares subject to possible redemption in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable equity instruments in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A ordinary shares in permanent equity, or total shareholders’ equity. Although the Company did not specify a maximum redemption threshold, its Amended and Restated Memorandum and Articles of Association currently provides that the Company will not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. The Company revised this interpretation to include temporary equity in net tangible assets. Therefore, on November 15, 2021, the Company’s management and the audit committee of the Company’s board of directors (the “Audit Committee”), after consultation with Marcum LLP, the Company’s independent registered public accounting firm, concluded that the Company’s previously issued (i) audited balance sheet as of January 28, 2020, as previously revised in the Company’s Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2020, filed with the SEC on July 14, 2021 (the “2020 Form 10-K/A No. 1”); (ii) audited financial statements included in the Company’s 2020 Form 10-K/A No. 1; and (iii) unaudited interim financial statements included in Form 10-Q for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020, filed with the SEC on May 14, 2020, August 14, 2020 and November 9, 2020, respectively (collectively, the “Affected Periods”), should be restated to report all Public Shares as temporary equity and should no longer be relied upon. We do not expect any of the above changes will have any impact on the Company’s cash position and cash held in the trust account established in connection with the IPO (the “Trust Account”). The Company’s management has concluded that in light of the classification error described above, a material weakness exists in the Company’s internal control over financial reporting and that the Company’s disclosure controls and procedures were not effective. The Company’s remediation plan with respect to such material weakness will be described in more detail in the Form 10-Q for the quarterly period ended September 30, 2021. We are filing this Amendment No. 2 to include additional risk factors under Item 1A, the Management’s Discussion and Analysis of Financial Condition and Results of Operation described in Item 7, Financial Statements and Supplementary Data described in Item 8, Part II, Item 9A Controls and Procedures, which such financial data give effect to the change in accounting for the Public Shares the Warrants as disclosed in the Original Filing, and the Controls and Procedures in Item 9A. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Item 1A, Risk Factors, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operation, Item 8, Financial Statements and Supplementary Data, and Item 9A, Controls and Procedures, of the Original Filing are hereby amended and restated in their entirety. This Amendment No. 2 should be read in conjunction with the Original Filing and the 2020 Form 10-K/A No. 1and with our filings with the SEC subsequent to the Original Filing 2020 Form 10-K/A No. 1. This Amendment No. 2 does not reflect events occurring after the filing of the Original Filing, and, except as described above, does not modify or update any other disclosures in the Original Filing. | ||
Entity Central Index Key | 0001794717 | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Well-known Seasoned Issuer | No | ||
Document Period End Date | Dec. 31, 2020 | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Shell Company | true | ||
Entity Ex Transition Period | false | ||
Entity File Number | 001-39190 | ||
Entity Incorporation, State or Country Code | E9 | ||
Entity Interactive Data Current | Yes | ||
Class A ordinary shares | |||
Document Information Line Items | |||
Entity Common Stock, Shares Outstanding | 23,000,000 | ||
Class B ordinary shares | |||
Document Information Line Items | |||
Entity Common Stock, Shares Outstanding | 5,750,000 |
Balance Sheets
Balance Sheets - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Current assets: | ||
Cash | $ 917,238 | $ 25,000 |
Prepaid expenses | 61,423 | |
Total current assets | 978,661 | 25,000 |
Investments held in Trust Account | 230,548,847 | |
Deferred offering costs associated with initial public offering | 407,703 | |
Total Assets | 231,527,508 | 432,703 |
Current liabilities: | ||
Accounts payable | 1,001,499 | 12,378 |
Accrued expenses | 6,000 | 306,474 |
Accrued expenses - related party | 120,000 | |
Note payable – related party | 110,065 | |
Total current liabilities | 1,127,499 | 428,917 |
Deferred underwriting commissions | 8,050,000 | |
Warrant liabilities | 31,298,000 | |
Total Liabilities | 40,475,499 | 428,917 |
Commitments and Contingencies (Note 6) | ||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 and 0 shares at $10.00 per share as of December 31, 2020 and 2019, respectively | 230,548,847 | |
Shareholders’ Equity (Deficit): | ||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2020 and 2019 | ||
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding as of December 31, 2020 and 2019 | 575 | 575 |
Additional paid-in capital | 24,425 | |
Accumulated deficit | (39,497,413) | (21,214) |
Total shareholders’ equity (deficit) | (39,496,838) | 3,786 |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) | $ 231,527,508 | $ 432,703 |
Balance Sheets (Parentheticals)
Balance Sheets (Parentheticals) - $ / shares | Dec. 31, 2020 | Dec. 31, 2019 |
Preference shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preference shares, shares authorized | 1,000,000 | 1,000,000 |
Preference shares, shares issued | 0 | 0 |
Preference shares, shares outstanding | 0 | 0 |
Class A ordinary shares | ||
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, subject to possible redemption | 23,000,000 | 0 |
Ordinary shares, subject to possible redemption par value (in Dollars per share) | $ 10 | $ 10 |
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Class B ordinary shares | ||
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares authorized | 20,000,000 | 20,000,000 |
Ordinary shares, shares issued | 5,750,000 | 5,750,000 |
Ordinary shares, shares outstanding | 5,750,000 | 5,750,000 |
Statements of Operations
Statements of Operations - USD ($) | 2 Months Ended | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2020 | ||
Operating expenses | |||
General and administrative expenses | $ 21,214 | $ 2,852,440 | |
Administrative fees - related party | 120,000 | ||
Loss from operations | (21,214) | (2,972,440) | |
Other income (expense): | |||
Change in fair value of warrant liabilities | (9,906,000) | ||
Offering costs associated with issuance of public and private warrants | (790,510) | ||
Net gain from investments held in Trust Account | 548,847 | ||
Net Loss | $ (21,214) | $ (13,120,103) | |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | 21,303,279 | ||
Basic and diluted net loss per Class A ordinary share (in Dollars per share) | $ (0.49) | ||
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | [1] | 5,000,000 | 5,694,672 |
Basic and diluted net loss per Class B ordinary share (in Dollars per share) | $ 0 | $ (0.49) | |
[1] | At December 31, 2019, this number excludes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On January 28, 2020, the underwriters fully exercised the over-allotment option; thus, these shares were no longer subject to forfeiture. |
Statements of Changes in Shareh
Statements of Changes in Shareholders’ Equity - USD ($) | Class AOrdinary Shares | Class BOrdinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Nov. 14, 2019 | |||||
Balance (in Shares) at Nov. 14, 2019 | |||||
Issuance of Class B ordinary shares to Sponsor | $ 575 | 24,425 | 25,000 | ||
Issuance of Class B ordinary shares to Sponsor (in Shares) | 5,750,000 | ||||
Net income (loss) | (21,214) | (21,214) | |||
Balance at Dec. 31, 2019 | $ 575 | 24,425 | (21,214) | 3,786 | |
Balance (in Shares) at Dec. 31, 2019 | 5,750,000 | ||||
Accretion on Class A ordinary shares subject to possible redemption amount | (24,425) | (26,356,096) | (26,380,521) | ||
Net income (loss) | (13,120,103) | (13,120,103) | |||
Balance at Dec. 31, 2020 | $ 575 | $ (39,497,413) | $ (39,496,838) | ||
Balance (in Shares) at Dec. 31, 2020 | 5,750,000 |
Statements of Cash Flows
Statements of Cash Flows - USD ($) | 2 Months Ended | 12 Months Ended |
Dec. 31, 2019 | Dec. 31, 2020 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (21,214) | $ (13,120,103) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
General and administrative expenses paid by related party included in note payable | 8,836 | 24,378 |
Change in fair value of warrant liabilities | 9,906,000 | |
Share based compensation | 1,452,000 | |
Offering costs associated with issuance of public and private warrants | 790,510 | |
Unrealized gain from Investments held in Trust Account | (548,847) | |
Changes in operating assets and liabilities: | ||
Prepaid expenses | (61,423) | |
Accounts payable | 12,378 | 989,121 |
Accrued expenses | 1,000 | |
Accrued expenses - related party | 120,000 | |
Net cash used in operating activities | (447,364) | |
Cash Flows from Investing Activities | ||
Cash deposited in Trust Account | (230,000,000) | |
Net cash used in investing activities | (230,000,000) | |
Cash Flows from Financing Activities: | ||
Proceeds received from initial public offering, gross | 230,000,000 | |
Proceeds from private placement | 6,600,000 | |
Proceeds from issuance of ordinary shares to initial shareholders | 25,000 | |
Offering costs paid | (5,121,355) | |
Repayment of note payable from related party | (139,043) | |
Net cash provided by financing activities | 25,000 | 231,339,602 |
Net change in cash | 25,000 | 892,238 |
Cash - beginning of the period | 25,000 | |
Cash - end of the period | 25,000 | 917,238 |
Supplemental disclosure of noncash investing and financing activities: | ||
Offering costs included in accrued expenses | 306,474 | 5,000 |
Offering costs included in note payable | 101,229 | 4,600 |
Deferred underwriting commissions in connection with the initial public offering | 8,050,000 | |
Accretion of Class A ordinary shares subject to redemption amount | $ 26,380,521 |
Description of Organization, Bu
Description of Organization, Business Operations and Going Concern | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Description of Organization, Business Operations and Going Concern | Note 1—Description of Organization, Business Operations and Going Concern Organization and General SCVX Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on November 15, 2019. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search for a target business in the cybersecurity sector. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from November 15, 2019 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering described below, and, since the closing of the Initial Public Offering (as defined below), the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. Sponsor and Financing The Company’s sponsor is SCVX USA LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on January 23, 2020. On January 28, 2020, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units”), each Unit consists of one Class A ordinary share (the “Public Shares”) and one-half of one redeemable warrant (the “Public Warrants”), including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.3 million, inclusive of $8.1 million in deferred underwriting commissions (Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,600,000 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $6.6 million, and incurring offering costs of approximately $21,000 (Note 5). Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $230.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and was invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act (as defined below), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares are classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s Chief Financial Officer (or his or her designee) prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or January 28, 2022 (the “Combination Period”) or (b) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern As of December 31, 2020, the Company had approximately $917,000 of cash in its operating account and working capital deficit of approximately $149,000. Prior to the completion of the Initial Public Offering and Private Placement, the Company’s liquidity needs were satisfied through a capital contribution of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, and a borrowing of approximately $139,000 under the Note (as defined below) issued to the Sponsor. The Company fully repaid the Note to the Sponsor on January 28, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, provide the Company with Working Capital Loans (as defined below in Note 5). The Working Capital Loans will either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 205-40, “Basis of Presentation – Going Concern,” management has determined that the working capital deficit raises substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, January 28, 2022. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Restatement of Previously Issue
Restatement of Previously Issued Financial Statements | 12 Months Ended |
Dec. 31, 2020 | |
Condensed Financial Information Disclosure [Abstract] | |
Restatement of Previously Issued Financial Statements | Note 2—Restatement of Previously Issued Financial Statements Amendment No. 1 In May 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its warrants issued in connection with the initial public offering and private placement in January 2020, the Company’s previously issued financial statements as of and for the year ended December 31, 2020, as of and for the three and nine months ended September 30, 2020, as of and for the three and six months ended June 30, 2020 and as of and for the three months ended March 31, 2020 (collectively, the “Affected Periods”) should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Periods included in this Annual Report. On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since issuance on January 28, 2020, the Company’s Warrants were accounted for as equity within the Company’s previously reported balance sheets, and after discussion and evaluation, including with the Company’s independent auditors, management concluded that the outstanding Warrants should be presented as liabilities with subsequent fair value remeasurement. Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued on January 28, 2020, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period. Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued financial statements for the Affected Periods should be restated because of a misapplication in the guidance around accounting for the Warrants should no longer be relied upon. The impact of the restatement on the balance sheets, statements of operations, statement of shareholders’ equity and statements of cash flows for the Affected Periods is presented below. As of December 31, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 231,527,508 $ - $ 231,527,508 Liabilities and shareholders’ equity Total current liabilities $ 1,127,499 $ - $ 1,127,499 Deferred underwriting commissions 8,050,000 - 8,050,000 Warrant liabilities - 31,298,000 31,298,000 Total liabilities 9,177,499 31,298,000 40,475,499 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 217,350,000 (31,298,000 ) 186,052,000 Shareholders’ equity Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 126 313 439 Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 5,992,115 12,148,197 18,140,312 Accumulated deficit (992,807 ) (12,148,510 ) (13,141,317 ) Total shareholders’ equity 5,000,009 - 5,000,009 Total liabilities and shareholders’ equity $ 231,527,508 $ - $ 231,527,508 For the Year Ended December 31, 2020 As Previously Restatement As Restated Statement of Operations General and administrative expenses $ 1,400,440 $ 1,452,000 $ 2,852,440 Administrative fees - related party 120,000 - 120,000 Loss from operations (1,520,440 ) (1,452,000 ) (2,972,440 ) Change in fair value of warrant liabilities - (9,906,000 ) (9,906,000 ) Offering costs associated with issuance of public and private warrants - (790,510 ) (790,510 ) Net gain from investments held in Trust Account 548,847 - 548,847 Net loss $ (971,593 ) $ (12,148,510 ) $ (13,120,103 ) Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted 21,819,737 (1,857,759 ) 19,961,978 Basic and diluted net income per share, Class A ordinary shares subject to possible redemption $ 0.02 $ - $ 0.02 Weighted average shares outstanding of non-redeemable ordinary shares, basic and diluted 6,787,867 1,720,711 8,508,578 Basic and diluted net loss per share, non-redeemable ordinary shares $ (0.22 ) $ (1.37 ) $ (1.59 ) Ordinary Shares Additional Total Class A Class B Paid-in Accumulated Shareholders’ Shares Amount Shares Amount Capital Deficit Equity Class A ordinary shares - as previously reported 1,265,000 $ 126 - $ - $ 5,992,115 $ - $ 5,992,241 Class A ordinary shares - restatement adjustment 3,129,800 313 - - 12,148,197 - 12,148,510 Class A ordinary shares - as restated 4,394,800 439 - - 18,140,312 - 18,140,751 Accumulated deficit - as previously reported - - - - - (992,807 ) (992,807 ) Accumulated deficit - restatement adjustment - - - - - (12,148,510 ) (12,148,510 ) Accumulated deficit - as restated - - - - - (13,141,317 ) (13,141,317 ) Balance at December 31, 2020 - as previously reported 1,265,000 126 5,750,000 575 5,992,115 (992,807 ) 5,000,009 Balance at December 31, 2020 - restatement adjustment 3,129,800 313 - - 12,148,197 (12,148,510 ) - Balance at December 31, 2020 - as restated 4,394,800 439 5,750,000 575 18,140,312 (13,141,317 ) 5,000,009 For the Year Ended December 31, 2020 As Previously Restatement As Restated Statement of Cash Flows Net loss $ (971,593 ) $ (12,148,510 ) $ (13,120,103 ) Change in fair value of warrant liabilities - 9,906,000 9,906,000 Share based compensation - 1,452,000 1,452,000 Offering costs associated with issuance of public and private warrants - (790,510 ) (790,510 ) Net cash used in operating activities (447,364 ) - (447,364 ) Net cash used in investing activities (230,000,000 ) - (230,000,000 ) Net cash provided by financing activities 231,339,602 - 231,339,602 Net change in cash $ 892,238 $ - $ 892,238 Amendment No. 2 In preparation of the Company’s unaudited condensed financial statements as of and for quarterly period ended September 30, 2021, the Company concluded it should restate its financial statements to classify all Class A ordinary shares subject to possible redemption in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable equity instruments in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A ordinary shares in permanent equity, or total shareholders’ equity. Although the Company did not specify a maximum redemption threshold, its Amended and Restated Memorandum and Articles of Association currently provides that the Company will not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. The Company revised this interpretation to include temporary equity in net tangible assets. In connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its income (loss) per common share calculation to allocate net income (loss) proportionately to Class A and Class B common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the income (loss) of the Company. Therefore, on November 15, 2021, the Company’s management and the audit committee of the Company’s board of directors (the “Audit Committee”) concluded that the Company’s previously issued (i) audited balance sheet as of January 28, 2020, as previously revised in the Company’s Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2020, filed with the SEC on July 14, 2021 (the “2020 Form 10-K/A No. 1”); (ii) audited financial statements included in the Company’s 2020 Form 10-K/A No. 1; and (iii) unaudited interim financial statements included in Form 10-Q for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020, filed with the SEC on May 14, 2020, August 14, 2020 and November 9, 2020, respectively (collectively, the “Affected Periods”), should no longer be relied upon and should be restated to report all Public Shares as temporary equity. Impact of the Restatement The impact of the restatement on the balance sheets, statements of operations, statement of shareholders’ equity and statements of cash flows for the Affected Periods is presented below. See Note 12 for restated quarterly financial information. As of December 31, 2020 As Previously Reported Adjustment As Restated Balance Sheet Total Assets $ 231,527,508 - $ 231,527,508 Total liabilities $ 40,475,499 - $ 40,475,499 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 186,052,000 44,496,847 230,548,847 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 439 (439 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 18,140,312 (18,140,312 ) - Accumulated deficit (13,141,317 ) (26,356,096 ) (39,497,413 ) Total shareholders’ equity (deficit) 5,000,009 (44,496,847 ) (39,496,838 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,527,508 $ - $ 231,527,508 For the Year Ended December 31, 2020 As Previously Reported Adjustment As Restated Statement of Operations Loss from operations $ (2,972,440 ) $ - $ (2,972,440 ) Other (expense) income: - Change in fair value of warrant liabilities (9,906,000 ) - (9,906,000 ) Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 548,847 - 548,847 Total other expense (10,147,663 ) - (10,147,663 ) Net loss $ (13,120,103 ) $ - $ (13,120,103 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 19,961,978 1,341,301 21,303,279 Basic and diluted net income (loss) per Class A ordinary share $ 0.02 $ (0.51 ) $ (0.49 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 8,508,578 (2,813,906 ) 5,694,672 Basic and diluted net loss per Class B ordinary share $ (1.59 ) $ 1.10 $ (0.49 ) Ordinary Shares Additional Total Class A Class B Paid-in Accumulated Equity Shares Amount Shares Amount Capital Deficit (Deficit) Statement of Shareholders’ Equity Class A ordinary shares - as previously reported 4,394,800 $ 439 - $ - $ 18,140,312 $ - $ 18,140,751 Class A ordinary shares - restatement adjustment (4,394,800 ) (439 ) - - (18,140,312 ) - (18,140,751 ) Class A ordinary shares - as restated - - - - - - - Accumulated deficit - as previously reported - - - - - (13,141,317 ) (13,141,317 ) Accumulated deficit - restatement adjustment - - - - - (26,356,096 ) (26,356,096 ) Accumulated deficit - as restated - - - - - (39,497,413 ) (39,497,413 ) Balance at December 31, 2020 - as previously reported 4,394,800 439 5,750,000 575 18,140,312 (13,141,317 ) 5,000,009 Balance at December 31, 2020 - restatement adjustment (4,394,800 ) (439 ) - - (18,140,312 ) (26,356,096 ) (44,496,847 ) Balance at December 31, 2020 - as restated - - 5,750,000 575 - (39,497,413 ) (39,496,838 ) For the Year Ended December 31, 2020 As Previously Reported Adjustment As Restated Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ (10,875,450 ) $ 10,875,450 $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,380,521 $ 26,380,521 |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Summary of Significant Accounting Policies | Note 3—Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for the Affected Periods are restated in this Annual Report on Form 10-K/A (Amendment No. 2) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s Class A ordinary shares subject to redemption and Warrants in the Company’s previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2020 and 2019 within the operating cash account. The entire balance of investments held in Trust Account as of December 31, 2020 is comprised of cash equivalents. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Share Based Compensation The Company records non-cash compensation recognized as a result of the fair value of the Private Placement Warrants being in excess of the amount paid by the Sponsor, pursuant to ASC 718, Share-based Compensation. Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements” (“ASC 820”) approximates the carrying amounts represented in the balance sheet. As of December 31, 2020 and 2019, the carrying values of cash, accounts payable, accrued expenses and accrued expenses – related party approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering.” Offering costs consist of costs incurred in connection with the formation and preparation for the Initial Public Offering, including the underwriting discount. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Class A ordinary shares were charged to the initial carrying value of temporary equity upon the completion of the Initial Public Offering. Class A Ordinary Shares Subject to Possible Redemption Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption at the redemption amount are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average number of ordinary shares outstanding for the respective period The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase 18,100,000 Class A ordinary shares because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period presented. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares: For the Year Ended For the Period from December 31, 2020 December 31, 2019 Class A Class B Class A Class B Numerator: Allocation of net loss $ (10,352,682 ) $ (2,767,421 ) $ - $ (21,214 ) Denominator: Weighted average ordinary shares outstanding, basic and diluted 21,303,279 5,694,672 - 5,000,000 Basic and diluted net loss per ordinary share $ (0.49 ) $ (0.49 ) $ - $ (0.00 ) Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020 and 2019. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision is zero as of December 31, 2020 and 2019. Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 18,100,000 ordinary shares warrants issued in connection with the Initial Public Offering (11,500,000) and Private Placement (6,600,000) as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulations at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation model at each measurement date and subsequently been measured based on the market price when separately listed and traded. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have an effect on the Company’s financial statements. |
Initial Public Offering
Initial Public Offering | 12 Months Ended |
Dec. 31, 2020 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 4—Initial Public Offering On January 28, 2020, the Company sold 23,000,000 Units, including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit in the Initial Public Offering. Each Unit consists of one Class A ordinary share, and one-half of one Public Warrant. Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (Note 6). |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2020 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 5—Related Party Transactions Founder Shares In November 2019, the Sponsor purchased 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), for an aggregate price of $25,000. In December 2019, the Sponsor transferred an aggregate of 1,092,500 Founder Shares to members of the Company’s management team. The holders of the Founder Shares had agreed to forfeit up to an aggregate of 750,000 Founder Shares, on a pro rata basis, to the extent that the over-allotment option was not exercised in full by the underwriters. On January 28, 2020, the over-allotment option was exercised in full. Accordingly, no Founder Shares were forfeited. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (1) one year after the completion of the initial Business Combination and (2) the date on which the Company consummates a liquidation, merger, share exchange, reorganization, or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lock-up. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,600,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $6.6 million, and incurring offering costs of approximately $21,000. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. Certain proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On November 19, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed approximately $139,000 under the Note and fully repaid this amount on January 28, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of December 31, 2020, the Company had no borrowings under any Working Capital Loans. Administrative Support Agreement Commencing on the date that the Company’s securities were first listed on the New York Stock Exchange, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, administrative and support services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $120,000 in expenses in connection with such services during the year ended December 31, 2020, as reflected in the accompanying statements of operations. As of December 31, 2020, an aggregate of $120,000 in accrued expenses with related party was outstanding, as reflected in the accompanying balance sheets. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 6—Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised their over-allotment option on January 28, 2020. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.6 million in the aggregate, which was paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $8.1 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. |
Derivative Warrant Liabilities
Derivative Warrant Liabilities | 12 Months Ended |
Dec. 31, 2020 | |
Derivative Warrant Liabilities [Abstract] | |
Derivative Warrant Liabilities | Note 7—Derivative Warrant Liabilities Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, the Company will use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. If the shares issuable upon exercise of the warrants are not registered under the Securities Act, the Company will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects, the Company will not be required to file or maintain in effect a registration statement, but the Company will use its reasonable best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the ordinary shares during the 20-trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per Warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of the Class A ordinary share equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. |
Class A Ordinary Shares Subject
Class A Ordinary Shares Subject to Possible Redemption (Restated) | 12 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Class A Ordinary Shares Subject to Possible Redemption (Restated) | Note 8 – Class A Ordinary Shares Subject to Possible Redemption (Restated) The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2020, there were 23,000,000 Class A ordinary shares issued and subject to possible redemption. As of December 31, 2020, Class A ordinary shares reflected on the balance sheet is reconciled on the following table: As of Gross proceeds received from Initial Public Offering $ 230,000,000 Less: Fair value of Public Warrants at issuance (13,340,000 ) Offering costs allocated to Class A ordinary shares (12,491,674 ) Plus: Accretion on Class A ordinary shares to redemption value 26,380,521 Class A ordinary shares subject to possible redemption $ 230,548,847 |
Shareholders' Equity
Shareholders' Equity | 12 Months Ended |
Dec. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Shareholders' Equity | Note 9—Shareholders’ Equity Class A Ordinary Shares Class B Ordinary Shares Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided, that, prior to the Company’s initial Business Combination, holders of the Class B ordinary shares will have the right to elect all of the Company’s directors and remove members of the board of directors for any reason, and holders of the Class A ordinary shares will not be entitled to vote on the election of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the Initial Business Combination on a one-for-one basis, subject to adjustment for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of all ordinary shares issued and outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination. Preferred Shares |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 10—Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: ● Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. ● Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. ● Level 3: Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December 31, 2020 and 2019 by level within the fair value hierarchy: Fair Value Measured as of December 31, 2020 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account - money market fund $ 230,548,847 $ - $ - $ 230,548,847 Liabilities: Warrant liabilities - public warrants (restated) $ 19,550,000 $ - $ - $ 19,550,000 Warrant liabilities - private warrants (restated) $ - $ - $ 11,748,000 $ 11,748,000 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in March 2021, when the Public Warrants were separately listed and traded. The fair value of warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulations at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation model at each measurement date and subsequently been measured based on the market price when separately listed and traded. The Company recognized approximately $21.4 million for the derivative warrant liabilities upon their issuance on January 28, 2020. For the year ended December 31, 2020, the Company recognized a charge to the statements of operations resulting from an increase in the fair value of liabilities of approximately $9.9 million presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2020 is summarized as follows: Warrant liabilities at January 1, 2020 $ - Issuance of public and private warrants 21,392,000 Change in fair value of warrant liabilities 9,906,000 Warrant liabilities at December 31, 2020 $ 31,298,000 The estimated fair value of the derivative warrant liabilities is determined using Level 3 inputs. Inherent in a Monte-Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: December 31, September 30, June 30, March 31, January 28, Exercise price $ 11.50 $ 11.50 $ 11.50 $ 11.50 $ 11.50 Stock Price $ 10.30 $ 10.00 $ 9.96 $ 9.50 $ 9.42 Term (in years) 5.58 5.83 6.08 6.33 6.50 Volatility 24.50 % 23.10 % 16.90 % 10.50 % 18.40 % Risk-free interest rate 0.44 % 0.36 % 0.40 % 0.49 % 1.54 % Dividend yield - - - - - |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 11—Subsequent Events Management has evaluated subsequent events to determine if events or transactions occurring through the date the financial statements were issued required potential adjustment to or disclosure in the financial statements and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed. |
Quarterly Financial Information
Quarterly Financial Information (Unaudited) | 12 Months Ended |
Dec. 31, 2020 | |
Quarterly Financial Information Disclosure [Abstract] | |
Quarterly Financial Information (Unaudited) | Note 12—Quarterly Financial Information (Unaudited) The following tables contain unaudited quarterly financial information for the quarterly periods ended September 30, 2020, June 30, 2020 and March 31, 2020 that has been updated to reflect the restatement of the Company’s financial statements as described in Note 2—Restatement of Previously Issued Financial Statements. The Company has not amended its previously filed Quarterly Reports on Form 10-Q for the Affected Periods. The financial information that has been previously filed or otherwise reported for the Affected Periods are superseded by the information in this Annual Report, and the financial statements and related financial information for the Affected Periods contained in such previously filed reports should no longer be relied upon. As of March 31, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Balance Sheet Total Assets $ 231,737,329 - $ 231,737,329 Total liabilities $ 15,543,013 - $ 15,543,013 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 211,194,310 19,088,637 230,282,947 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 188 (188 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital (7,001,747 ) 7,001,747 - Accumulated deficit 12,000,990 (26,090,196 ) (14,089,206 ) Total shareholders’ equity (deficit) 5,000,006 (19,088,637 ) (14,088,631 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,737,329 $ - $ 231,737,329 For the Three Months Ended March 31, 2020 As Previously Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (1,622,233 ) $ - $ (1,622,233 ) Other (expense) income: Change in fair value of warrant liabilities 14,152,000 - 14,152,000 Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 282,947 - 282,947 Total other (expense) income 13,644,437 - 13,644,437 Net income $ 12,022,204 $ - $ 12,022,204 Weighted average shares outstanding of Class A ordinary shares, basic and diluted 19,715,037 (3,539,213 ) 16,175,824 Basic and diluted net income per Class A ordinary share $ 0.01 $ 0.54 $ 0.55 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 7,837,776 (2,310,304 ) 5,527,473 Basic and diluted net income per Class B ordinary share $ 1.50 $ (0.95 ) $ 0.55 For the Three Months Ended March 31, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ 14,266,860 $ (14,266,860 ) $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,114,621 $ 26,114,621 As of June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Balance Sheet Total Assets $ 231,677,875 - $ 231,677,875 Total liabilities $ 26,947,235 - $ 26,947,235 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 199,730,637 30,793,051 230,523,688 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 307 (307 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 4,461,807 (4,461,807 ) - Accumulated deficit 537,314 (26,330,937 ) (25,793,623 ) Total shareholders’ equity (deficit) 5,000,003 (30,793,051 ) (25,793,048 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,677,875 $ - $ 231,677,875 For the Three Months Ended June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (120,417 ) $ - $ (120,417 ) Other (expense) income: Change in fair value of warrant liabilities (11,584,000 ) - (11,584,000 ) Net gain from investments held in Trust Account 240,741 - 240,741 Total other expense (11,343,259 ) - (11,343,259 ) Net loss $ (11,463,676 ) $ - $ (11,463,676 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 21,106,354 1,893,646 23,000,000 Basic and diluted net income (loss) per Class A ordinary share $ 0.01 $ (0.41 ) $ (0.40 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 7,643,646 (1,893,646 ) 5,750,000 Basic and diluted net loss per Class B ordinary share $ (1.53 ) $ 1.13 $ (0.40 ) For the Six Months Ended June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (1,742,650 ) $ - $ (1,742,650 ) Other (expense) income: - Change in fair value of warrant liabilities 2,568,000 - 2,568,000 Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 523,688 - 523,688 Total other income 2,301,178 - 2,301,178 Net income $ 558,528 $ - $ 558,528 Weighted average shares outstanding of Class A ordinary shares, basic and diluted 17,485,937 2,101,975 19,587,912 Basic and diluted net income per Class A ordinary share $ 0.03 $ (0.01 ) $ 0.02 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 7,740,711 (2,101,975 ) 5,638,736 Basic and diluted net income per Class B ordinary share $ 0.01 $ 0.01 $ 0.02 For the Six Months Ended June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ 2,803,187 $ (2,803,187 ) $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,355,362 $ 26,355,362 As of September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Balance Sheet Total Assets $ 231,600,223 - $ 231,600,223 Total liabilities $ 35,676,701 - $ 35,676,701 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 190,923,515 39,621,026 230,544,541 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 395 (395 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 13,268,841 (13,268,841 ) - Accumulated deficit (8,269,804 ) (26,351,790 ) (34,621,594 ) Total shareholders’ equity (deficit) 5,000,007 (39,621,026 ) (34,621,019 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,600,223 $ - $ 231,600,223 For the Three Months Ended September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (171,971 ) $ - $ (171,971 ) Other (expense) income: Change in fair value of warrant liabilities (8,656,000 ) - (8,656,000 ) Net gain from investments held in Trust Account 20,853 - 20,853 Total other expense (8,635,147 ) - (8,635,147 ) Net loss $ (8,807,118 ) $ - $ (8,807,118 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 19,919,867 3,080,133 23,000,000 Basic and diluted net income (loss) per Class A ordinary share $ 0.00 $ (0.31 ) $ (0.31 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 8,830,133 (3,080,133 ) 5,750,000 Basic and diluted net loss per Class B ordinary share $ (1.00 ) $ 0.69 $ (0.31 ) For the Nine Months Ended September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (1,914,621 ) $ - $ (1,914,621 ) Other (expense) income: - Change in fair value of warrant liabilities (6,088,000 ) - (6,088,000 ) Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 544,541 - 544,541 Total other expense (6,333,969 ) - (6,333,969 ) Net loss $ (8,248,590 ) $ - $ (8,248,590 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 18,303,169 2,430,407 20,733,577 Basic and diluted net income (loss) per Class A ordinary share $ 0.02 $ (0.33 ) $ (0.31 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 8,106,502 (2,430,407 ) 5,676,095 Basic and diluted net loss per Class B ordinary share $ (1.07 ) $ 0.76 $ (0.31 ) For the Nine Months Ended September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ (6,003,935 ) $ 6,003,935 $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,376,215 $ 26,376,215 Restated Unaudited Condensed Statements of Changes in Shareholders’ Equity For the three months ended March 31, 2020, the three and six months ended June 30, 2020 and the three and nine months ended September 30, 2020 Ordinary Shares Additional Total Class A Class B Paid-in Accumulated Equity Shares Amount Shares Amount Capital Deficit (Deficit) Balance - December 31, 2019 - $ - 5,750,000 $ 575 $ 24,425 $ (21,214 ) $ 3,786 Accretion on Class A ordinary shares subject to possible redemption amount - - - - (24,425 ) (26,090,196 ) (26,114,621 ) Net income - - - - - 12,022,204 12,022,204 Balance - March 31, 2020 (unaudited) - - 5,750,000 575 - (14,089,206 ) (14,088,631 ) Accretion on Class A ordinary shares subject to possible redemption amount - - - - - (240,741 ) (240,741 ) Net loss - - - - - (11,463,676 ) (11,463,676 ) Balance - June 30, 2020 (unaudited) - - 5,750,000 575 - (25,793,623 ) (25,793,048 ) Accretion on Class A ordinary shares subject to possible redemption amount - - - - - (20,853 ) (20,853 ) Net loss - - - - - (8,807,118 ) (8,807,118 ) Balance - September 30, 2020 (unaudited) - - 5,750,000 575 - (34,621,594 ) (34,621,019 ) Accretion on Class A ordinary shares subject to possible redemption amount - - - - - (4,306 ) (4,306 ) Net loss - - - - - (4,871,513 ) (4,871,513 ) Balance - December 31, 2020 (restated) - $ - 5,750,000 $ 575 $ - $ (39,497,413 ) $ (39,496,838 ) The following is a summary of the above adjustments to the respective periods in the amended unaudited condensed statements of changes in shareholder’s equity. Ordinary Shares Additional Total Class A Class B Paid-in Retained Equity Shares Amount Shares Amount Capital Earnings (Deficit) For the Three Months Ended March 31, 2020 Balance at March 31, 2020 - as previously reported 1,880,569 $ 188 5,750,000 $ 575 $ (7,001,747 ) $ 12,000,990 $ 5,000,006 Balance at March 31, 2020 - restatement adjustment (1,880,569 ) (188 ) - - 7,001,747 (26,090,196 ) (19,088,637 ) Balance at March 31, 2020 - as restated - - 5,750,000 575 - (14,089,206 ) (14,088,631 ) Ordinary Shares Additional Retained Earnings Total Class A Class B Paid-in (Accumulated Equity Shares Amount Shares Amount Capital Deficit) (Deficit) For the Six Months Ended June 30, 2020 Balance at June 30, 2020 - as previously reported 3,070,560 $ 307 5,750,000 $ 575 $ 4,461,807 $ 537,314 $ 5,000,003 Balance at June 30, 2020 - restatement adjustment (3,070,560 ) (307 ) - - (4,461,807 ) (26,330,937 ) (30,793,051 ) Balance at June 30, 2020 - as restated - - 5,750,000 575 - (25,793,623 ) (25,793,048 ) Ordinary Shares Additional Retained Earnings Total Class A Class B Paid-in (Accumulated Equity Shares Amount Shares Amount Capital Deficit) (Deficit) For the Nine Months Ended September 30, 2020 Balance at September 30, 2020 - as previously reported 3,951,242 $ 395 5,750,000 $ 575 $ 13,268,841 $ (8,269,804 ) $ 5,000,007 Balance at September 30, 2020 - restatement adjustment (3,951,242 ) (395 ) - - (13,268,841 ) (26,351,790 ) (39,621,026 ) Balance at September 30, 2020 - as restated - - 5,750,000 575 - (34,621,594 ) (34,621,019 ) |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for the Affected Periods are restated in this Annual Report on Form 10-K/A (Amendment No. 2) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s Class A ordinary shares subject to redemption and Warrants in the Company’s previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2020 and 2019 within the operating cash account. The entire balance of investments held in Trust Account as of December 31, 2020 is comprised of cash equivalents. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Share Based Compensation | Share Based Compensation The Company records non-cash compensation recognized as a result of the fair value of the Private Placement Warrants being in excess of the amount paid by the Sponsor, pursuant to ASC 718, Share-based Compensation. |
Investments Held in the Trust Account | Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. |
Financial Instruments | Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements” (“ASC 820”) approximates the carrying amounts represented in the balance sheet. As of December 31, 2020 and 2019, the carrying values of cash, accounts payable, accrued expenses and accrued expenses – related party approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities. |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering.” Offering costs consist of costs incurred in connection with the formation and preparation for the Initial Public Offering, including the underwriting discount. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Class A ordinary shares were charged to the initial carrying value of temporary equity upon the completion of the Initial Public Offering. |
Class A Ordinary Shares Subject to Possible Redemption | Class A Ordinary Shares Subject to Possible Redemption Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption at the redemption amount are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. |
Net Income (Loss) per Ordinary Share | Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average number of ordinary shares outstanding for the respective period The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase 18,100,000 Class A ordinary shares because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period presented. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares: For the Year Ended For the Period from December 31, 2020 December 31, 2019 Class A Class B Class A Class B Numerator: Allocation of net loss $ (10,352,682 ) $ (2,767,421 ) $ - $ (21,214 ) Denominator: Weighted average ordinary shares outstanding, basic and diluted 21,303,279 5,694,672 - 5,000,000 Basic and diluted net loss per ordinary share $ (0.49 ) $ (0.49 ) $ - $ (0.00 ) |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020 and 2019. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision is zero as of December 31, 2020 and 2019. |
Derivative warrant liabilities | Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 18,100,000 ordinary shares warrants issued in connection with the Initial Public Offering (11,500,000) and Private Placement (6,600,000) as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulations at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation model at each measurement date and subsequently been measured based on the market price when separately listed and traded. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have an effect on the Company’s financial statements. |
Restatement of Previously Iss_2
Restatement of Previously Issued Financial Statements (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Condensed Financial Information Disclosure [Abstract] | |
Schedule of restatement on the balance sheets | As of December 31, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 231,527,508 $ - $ 231,527,508 Liabilities and shareholders’ equity Total current liabilities $ 1,127,499 $ - $ 1,127,499 Deferred underwriting commissions 8,050,000 - 8,050,000 Warrant liabilities - 31,298,000 31,298,000 Total liabilities 9,177,499 31,298,000 40,475,499 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 217,350,000 (31,298,000 ) 186,052,000 Shareholders’ equity Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 126 313 439 Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 5,992,115 12,148,197 18,140,312 Accumulated deficit (992,807 ) (12,148,510 ) (13,141,317 ) Total shareholders’ equity 5,000,009 - 5,000,009 Total liabilities and shareholders’ equity $ 231,527,508 $ - $ 231,527,508 As of December 31, 2020 As Previously Reported Adjustment As Restated Balance Sheet Total Assets $ 231,527,508 - $ 231,527,508 Total liabilities $ 40,475,499 - $ 40,475,499 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 186,052,000 44,496,847 230,548,847 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 439 (439 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 18,140,312 (18,140,312 ) - Accumulated deficit (13,141,317 ) (26,356,096 ) (39,497,413 ) Total shareholders’ equity (deficit) 5,000,009 (44,496,847 ) (39,496,838 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,527,508 $ - $ 231,527,508 |
Schedule of restatement on operating statement | For the Year Ended December 31, 2020 As Previously Restatement As Restated Statement of Operations General and administrative expenses $ 1,400,440 $ 1,452,000 $ 2,852,440 Administrative fees - related party 120,000 - 120,000 Loss from operations (1,520,440 ) (1,452,000 ) (2,972,440 ) Change in fair value of warrant liabilities - (9,906,000 ) (9,906,000 ) Offering costs associated with issuance of public and private warrants - (790,510 ) (790,510 ) Net gain from investments held in Trust Account 548,847 - 548,847 Net loss $ (971,593 ) $ (12,148,510 ) $ (13,120,103 ) Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted 21,819,737 (1,857,759 ) 19,961,978 Basic and diluted net income per share, Class A ordinary shares subject to possible redemption $ 0.02 $ - $ 0.02 Weighted average shares outstanding of non-redeemable ordinary shares, basic and diluted 6,787,867 1,720,711 8,508,578 Basic and diluted net loss per share, non-redeemable ordinary shares $ (0.22 ) $ (1.37 ) $ (1.59 ) For the Year Ended December 31, 2020 As Previously Reported Adjustment As Restated Statement of Operations Loss from operations $ (2,972,440 ) $ - $ (2,972,440 ) Other (expense) income: - Change in fair value of warrant liabilities (9,906,000 ) - (9,906,000 ) Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 548,847 - 548,847 Total other expense (10,147,663 ) - (10,147,663 ) Net loss $ (13,120,103 ) $ - $ (13,120,103 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 19,961,978 1,341,301 21,303,279 Basic and diluted net income (loss) per Class A ordinary share $ 0.02 $ (0.51 ) $ (0.49 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 8,508,578 (2,813,906 ) 5,694,672 Basic and diluted net loss per Class B ordinary share $ (1.59 ) $ 1.10 $ (0.49 ) |
Schedule of restatement on statement of shareholders’ equity | Ordinary Shares Additional Total Class A Class B Paid-in Accumulated Shareholders’ Shares Amount Shares Amount Capital Deficit Equity Class A ordinary shares - as previously reported 1,265,000 $ 126 - $ - $ 5,992,115 $ - $ 5,992,241 Class A ordinary shares - restatement adjustment 3,129,800 313 - - 12,148,197 - 12,148,510 Class A ordinary shares - as restated 4,394,800 439 - - 18,140,312 - 18,140,751 Accumulated deficit - as previously reported - - - - - (992,807 ) (992,807 ) Accumulated deficit - restatement adjustment - - - - - (12,148,510 ) (12,148,510 ) Accumulated deficit - as restated - - - - - (13,141,317 ) (13,141,317 ) Balance at December 31, 2020 - as previously reported 1,265,000 126 5,750,000 575 5,992,115 (992,807 ) 5,000,009 Balance at December 31, 2020 - restatement adjustment 3,129,800 313 - - 12,148,197 (12,148,510 ) - Balance at December 31, 2020 - as restated 4,394,800 439 5,750,000 575 18,140,312 (13,141,317 ) 5,000,009 Ordinary Shares Additional Total Class A Class B Paid-in Accumulated Equity Shares Amount Shares Amount Capital Deficit (Deficit) Statement of Shareholders’ Equity Class A ordinary shares - as previously reported 4,394,800 $ 439 - $ - $ 18,140,312 $ - $ 18,140,751 Class A ordinary shares - restatement adjustment (4,394,800 ) (439 ) - - (18,140,312 ) - (18,140,751 ) Class A ordinary shares - as restated - - - - - - - Accumulated deficit - as previously reported - - - - - (13,141,317 ) (13,141,317 ) Accumulated deficit - restatement adjustment - - - - - (26,356,096 ) (26,356,096 ) Accumulated deficit - as restated - - - - - (39,497,413 ) (39,497,413 ) Balance at December 31, 2020 - as previously reported 4,394,800 439 5,750,000 575 18,140,312 (13,141,317 ) 5,000,009 Balance at December 31, 2020 - restatement adjustment (4,394,800 ) (439 ) - - (18,140,312 ) (26,356,096 ) (44,496,847 ) Balance at December 31, 2020 - as restated - - 5,750,000 575 - (39,497,413 ) (39,496,838 ) |
Schedule of restatement on cashflow statement | For the Year Ended December 31, 2020 As Previously Restatement As Restated Statement of Cash Flows Net loss $ (971,593 ) $ (12,148,510 ) $ (13,120,103 ) Change in fair value of warrant liabilities - 9,906,000 9,906,000 Share based compensation - 1,452,000 1,452,000 Offering costs associated with issuance of public and private warrants - (790,510 ) (790,510 ) Net cash used in operating activities (447,364 ) - (447,364 ) Net cash used in investing activities (230,000,000 ) - (230,000,000 ) Net cash provided by financing activities 231,339,602 - 231,339,602 Net change in cash $ 892,238 $ - $ 892,238 For the Year Ended December 31, 2020 As Previously Reported Adjustment As Restated Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ (10,875,450 ) $ 10,875,450 $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,380,521 $ 26,380,521 |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Schedule of basic and diluted loss per ordinary share | For the Year Ended For the Period from December 31, 2020 December 31, 2019 Class A Class B Class A Class B Numerator: Allocation of net loss $ (10,352,682 ) $ (2,767,421 ) $ - $ (21,214 ) Denominator: Weighted average ordinary shares outstanding, basic and diluted 21,303,279 5,694,672 - 5,000,000 Basic and diluted net loss per ordinary share $ (0.49 ) $ (0.49 ) $ - $ (0.00 ) |
Class A Ordinary Shares Subje_2
Class A Ordinary Shares Subject to Possible Redemption (Restated) (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of class A ordinary shares reflected on the balance sheet | As of Gross proceeds received from Initial Public Offering $ 230,000,000 Less: Fair value of Public Warrants at issuance (13,340,000 ) Offering costs allocated to Class A ordinary shares (12,491,674 ) Plus: Accretion on Class A ordinary shares to redemption value 26,380,521 Class A ordinary shares subject to possible redemption $ 230,548,847 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Schedule of assets that are measured at fair value on a recurring basis | Fair Value Measured as of December 31, 2020 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account - money market fund $ 230,548,847 $ - $ - $ 230,548,847 Liabilities: Warrant liabilities - public warrants (restated) $ 19,550,000 $ - $ - $ 19,550,000 Warrant liabilities - private warrants (restated) $ - $ - $ 11,748,000 $ 11,748,000 |
Schedule of change in the fair value of the derivative warrant liabilities | Warrant liabilities at January 1, 2020 $ - Issuance of public and private warrants 21,392,000 Change in fair value of warrant liabilities 9,906,000 Warrant liabilities at December 31, 2020 $ 31,298,000 |
Schedule of information regarding Level 3 fair value measurements inputs | December 31, September 30, June 30, March 31, January 28, Exercise price $ 11.50 $ 11.50 $ 11.50 $ 11.50 $ 11.50 Stock Price $ 10.30 $ 10.00 $ 9.96 $ 9.50 $ 9.42 Term (in years) 5.58 5.83 6.08 6.33 6.50 Volatility 24.50 % 23.10 % 16.90 % 10.50 % 18.40 % Risk-free interest rate 0.44 % 0.36 % 0.40 % 0.49 % 1.54 % Dividend yield - - - - - |
Quarterly Financial Informati_2
Quarterly Financial Information (Unaudited) (Tables) - Parant [Member] | 12 Months Ended |
Dec. 31, 2020 | |
Quarterly Financial Information (Unaudited) (Tables) [Line Items] | |
Schedule of balance sheet | As of March 31, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Balance Sheet Total Assets $ 231,737,329 - $ 231,737,329 Total liabilities $ 15,543,013 - $ 15,543,013 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 211,194,310 19,088,637 230,282,947 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 188 (188 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital (7,001,747 ) 7,001,747 - Accumulated deficit 12,000,990 (26,090,196 ) (14,089,206 ) Total shareholders’ equity (deficit) 5,000,006 (19,088,637 ) (14,088,631 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,737,329 $ - $ 231,737,329 As of June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Balance Sheet Total Assets $ 231,677,875 - $ 231,677,875 Total liabilities $ 26,947,235 - $ 26,947,235 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 199,730,637 30,793,051 230,523,688 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 307 (307 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 4,461,807 (4,461,807 ) - Accumulated deficit 537,314 (26,330,937 ) (25,793,623 ) Total shareholders’ equity (deficit) 5,000,003 (30,793,051 ) (25,793,048 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,677,875 $ - $ 231,677,875 As of September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Balance Sheet Total Assets $ 231,600,223 - $ 231,600,223 Total liabilities $ 35,676,701 - $ 35,676,701 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 190,923,515 39,621,026 230,544,541 Shareholders’ equity (deficit) Preferred shares - $0.0001 par value - - - Class A ordinary shares - $0.0001 par value 395 (395 ) - Class B ordinary shares - $0.0001 par value 575 - 575 Additional paid-in-capital 13,268,841 (13,268,841 ) - Accumulated deficit (8,269,804 ) (26,351,790 ) (34,621,594 ) Total shareholders’ equity (deficit) 5,000,007 (39,621,026 ) (34,621,019 ) Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) $ 231,600,223 $ - $ 231,600,223 |
Schedule of operation statement | For the Three Months Ended March 31, 2020 As Previously Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (1,622,233 ) $ - $ (1,622,233 ) Other (expense) income: Change in fair value of warrant liabilities 14,152,000 - 14,152,000 Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 282,947 - 282,947 Total other (expense) income 13,644,437 - 13,644,437 Net income $ 12,022,204 $ - $ 12,022,204 Weighted average shares outstanding of Class A ordinary shares, basic and diluted 19,715,037 (3,539,213 ) 16,175,824 Basic and diluted net income per Class A ordinary share $ 0.01 $ 0.54 $ 0.55 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 7,837,776 (2,310,304 ) 5,527,473 Basic and diluted net income per Class B ordinary share $ 1.50 $ (0.95 ) $ 0.55 For the Three Months Ended June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (120,417 ) $ - $ (120,417 ) Other (expense) income: Change in fair value of warrant liabilities (11,584,000 ) - (11,584,000 ) Net gain from investments held in Trust Account 240,741 - 240,741 Total other expense (11,343,259 ) - (11,343,259 ) Net loss $ (11,463,676 ) $ - $ (11,463,676 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 21,106,354 1,893,646 23,000,000 Basic and diluted net income (loss) per Class A ordinary share $ 0.01 $ (0.41 ) $ (0.40 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 7,643,646 (1,893,646 ) 5,750,000 Basic and diluted net loss per Class B ordinary share $ (1.53 ) $ 1.13 $ (0.40 ) For the Six Months Ended June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (1,742,650 ) $ - $ (1,742,650 ) Other (expense) income: - Change in fair value of warrant liabilities 2,568,000 - 2,568,000 Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 523,688 - 523,688 Total other income 2,301,178 - 2,301,178 Net income $ 558,528 $ - $ 558,528 Weighted average shares outstanding of Class A ordinary shares, basic and diluted 17,485,937 2,101,975 19,587,912 Basic and diluted net income per Class A ordinary share $ 0.03 $ (0.01 ) $ 0.02 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 7,740,711 (2,101,975 ) 5,638,736 Basic and diluted net income per Class B ordinary share $ 0.01 $ 0.01 $ 0.02 For the Three Months Ended September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (171,971 ) $ - $ (171,971 ) Other (expense) income: Change in fair value of warrant liabilities (8,656,000 ) - (8,656,000 ) Net gain from investments held in Trust Account 20,853 - 20,853 Total other expense (8,635,147 ) - (8,635,147 ) Net loss $ (8,807,118 ) $ - $ (8,807,118 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 19,919,867 3,080,133 23,000,000 Basic and diluted net income (loss) per Class A ordinary share $ 0.00 $ (0.31 ) $ (0.31 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 8,830,133 (3,080,133 ) 5,750,000 Basic and diluted net loss per Class B ordinary share $ (1.00 ) $ 0.69 $ (0.31 ) For the Nine Months Ended September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (1,914,621 ) $ - $ (1,914,621 ) Other (expense) income: - Change in fair value of warrant liabilities (6,088,000 ) - (6,088,000 ) Offering costs associated with issuance of public and private warrants (790,510 ) - (790,510 ) Net gain from investments held in Trust Account 544,541 - 544,541 Total other expense (6,333,969 ) - (6,333,969 ) Net loss $ (8,248,590 ) $ - $ (8,248,590 ) Weighted average shares outstanding of Class A ordinary shares, basic and diluted 18,303,169 2,430,407 20,733,577 Basic and diluted net income (loss) per Class A ordinary share $ 0.02 $ (0.33 ) $ (0.31 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 8,106,502 (2,430,407 ) 5,676,095 Basic and diluted net loss per Class B ordinary share $ (1.07 ) $ 0.76 $ (0.31 ) |
Schedule of statement of cash flows | For the Three Months Ended March 31, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ 14,266,860 $ (14,266,860 ) $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,114,621 $ 26,114,621 For the Six Months Ended June 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ 2,803,187 $ (2,803,187 ) $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,355,362 $ 26,355,362 For the Nine Months Ended September 30, 2020 As Previously Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities: Initial value of Class A ordinary shares subject to possible redemption $ 196,927,450 $ (196,927,450 ) $ - Change in fair value of Class A ordinary shares subject to possible redemption $ (6,003,935 ) $ 6,003,935 $ - Accretion of Class A ordinary shares subject to redemption amount $ - $ 26,376,215 $ 26,376,215 |
Schedule of stockholders equity | Ordinary Shares Additional Total Class A Class B Paid-in Accumulated Equity Shares Amount Shares Amount Capital Deficit (Deficit) Balance - December 31, 2019 - $ - 5,750,000 $ 575 $ 24,425 $ (21,214 ) $ 3,786 Accretion on Class A ordinary shares subject to possible redemption amount - - - - (24,425 ) (26,090,196 ) (26,114,621 ) Net income - - - - - 12,022,204 12,022,204 Balance - March 31, 2020 (unaudited) - - 5,750,000 575 - (14,089,206 ) (14,088,631 ) Accretion on Class A ordinary shares subject to possible redemption amount - - - - - (240,741 ) (240,741 ) Net loss - - - - - (11,463,676 ) (11,463,676 ) Balance - June 30, 2020 (unaudited) - - 5,750,000 575 - (25,793,623 ) (25,793,048 ) Accretion on Class A ordinary shares subject to possible redemption amount - - - - - (20,853 ) (20,853 ) Net loss - - - - - (8,807,118 ) (8,807,118 ) Balance - September 30, 2020 (unaudited) - - 5,750,000 575 - (34,621,594 ) (34,621,019 ) Accretion on Class A ordinary shares subject to possible redemption amount - - - - - (4,306 ) (4,306 ) Net loss - - - - - (4,871,513 ) (4,871,513 ) Balance - December 31, 2020 (restated) - $ - 5,750,000 $ 575 $ - $ (39,497,413 ) $ (39,496,838 ) Ordinary Shares Additional Total Class A Class B Paid-in Retained Equity Shares Amount Shares Amount Capital Earnings (Deficit) For the Three Months Ended March 31, 2020 Balance at March 31, 2020 - as previously reported 1,880,569 $ 188 5,750,000 $ 575 $ (7,001,747 ) $ 12,000,990 $ 5,000,006 Balance at March 31, 2020 - restatement adjustment (1,880,569 ) (188 ) - - 7,001,747 (26,090,196 ) (19,088,637 ) Balance at March 31, 2020 - as restated - - 5,750,000 575 - (14,089,206 ) (14,088,631 ) Ordinary Shares Additional Retained Earnings Total Class A Class B Paid-in (Accumulated Equity Shares Amount Shares Amount Capital Deficit) (Deficit) For the Six Months Ended June 30, 2020 Balance at June 30, 2020 - as previously reported 3,070,560 $ 307 5,750,000 $ 575 $ 4,461,807 $ 537,314 $ 5,000,003 Balance at June 30, 2020 - restatement adjustment (3,070,560 ) (307 ) - - (4,461,807 ) (26,330,937 ) (30,793,051 ) Balance at June 30, 2020 - as restated - - 5,750,000 575 - (25,793,623 ) (25,793,048 ) Ordinary Shares Additional Retained Earnings Total Class A Class B Paid-in (Accumulated Equity Shares Amount Shares Amount Capital Deficit) (Deficit) For the Nine Months Ended September 30, 2020 Balance at September 30, 2020 - as previously reported 3,951,242 $ 395 5,750,000 $ 575 $ 13,268,841 $ (8,269,804 ) $ 5,000,007 Balance at September 30, 2020 - restatement adjustment (3,951,242 ) (395 ) - - (13,268,841 ) (26,351,790 ) (39,621,026 ) Balance at September 30, 2020 - as restated - - 5,750,000 575 - (34,621,594 ) (34,621,019 ) |
Description of Organization, _2
Description of Organization, Business Operations and Going Concern (Details) - USD ($) | 1 Months Ended | 12 Months Ended |
Jan. 28, 2020 | Dec. 31, 2020 | |
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | ||
Incurring offering cost | $ 21,000 | |
Description related to trust account | Upon the closing of the Initial Public Offering and the Private Placement, $230.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and was invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act (as defined below), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. | |
Fair market value percentage | 80.00% | |
Net tangible assets | $ 5,000,001 | |
Redeeming percentage | 15.00% | |
Obligation redeem percentage | 100.00% | |
Description of business combination within the combination period | If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. | |
Per share value of residual asset (in Dollars per share) | $ 10 | |
Cash in operating account | $ 917,000 | |
Working capital | 149,000 | |
Capital contribution | 25,000 | |
Short term borrowings | $ 139,000 | |
Working capital loan description | The Working Capital Loans will either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. | |
Initial Public Offering [Member] | ||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | ||
Each unit of Initial public offering, description | On January 28, 2020, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units”), each Unit consists of one Class A ordinary share (the “Public Shares”) and one-half of one redeemable warrant (the “Public Warrants”), including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.3 million, inclusive of $8.1 million in deferred underwriting commissions (Note 6). | |
Number of units issued in transaction (in Shares) | 23,000,000 | |
Share price (in Dollars per share) | $ 0.0001 | |
Number of warrants (in Shares) | 11,500,000 | |
Price per share (in Dollars per share) | $ 10 | |
Over-Allotment Option [Member] | ||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | ||
Number of units issued in transaction (in Shares) | 3,000,000 | |
Share price (in Dollars per share) | $ 10 | |
Gross proceeds | $ 230,000,000 | |
Offering cost | 13,300,000 | |
Deferred underwriting commissions | $ 8,100,000 | |
Private Placement Warrant [Member] | ||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | ||
Share price (in Dollars per share) | $ 1 | |
Number of warrants (in Shares) | 6,600,000 | |
Proceeds from warrant | $ 6,600,000 | |
Series of Individually Immaterial Business Acquisitions [Member] | ||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | ||
Percentage of outstanding voting securities | 50.00% |
Restatement of Previously Iss_3
Restatement of Previously Issued Financial Statements (Details) | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Condensed Financial Information Disclosure [Abstract] | |
Net tangible assets | $ 5,000,001 |
Restatement of Previously Iss_4
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on the balance sheets | Dec. 31, 2020USD ($) |
As Previously Reported [Member] | |
Balance Sheet | |
Total assets | $ 231,527,508 |
Total current liabilities | 1,127,499 |
Deferred underwriting commissions | 8,050,000 |
Warrant liabilities | |
Total liabilities | 9,177,499 |
Preferred shares - $0.0001 par value | |
Additional paid-in-capital | 5,992,115 |
Accumulated deficit | (992,807) |
Total shareholders’ equity | 5,000,009 |
Total liabilities and shareholders’ equity | 231,527,508 |
Restatement Adjustment [Member] | |
Balance Sheet | |
Total assets | |
Total current liabilities | |
Deferred underwriting commissions | |
Warrant liabilities | 31,298,000 |
Total liabilities | 31,298,000 |
Preferred shares - $0.0001 par value | |
Additional paid-in-capital | 12,148,197 |
Accumulated deficit | (12,148,510) |
Total shareholders’ equity | |
Total liabilities and shareholders’ equity | |
As Restated [Member] | |
Balance Sheet | |
Total assets | 231,527,508 |
Total current liabilities | 1,127,499 |
Deferred underwriting commissions | 8,050,000 |
Warrant liabilities | 31,298,000 |
Total liabilities | 40,475,499 |
Preferred shares - $0.0001 par value | |
Additional paid-in-capital | 18,140,312 |
Accumulated deficit | (13,141,317) |
Total shareholders’ equity | 5,000,009 |
Total liabilities and shareholders’ equity | 231,527,508 |
Class A ordinary shares [Member] | As Previously Reported [Member] | |
Balance Sheet | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 217,350,000 |
Class A ordinary shares - $0.0001 par value | 126 |
Class A ordinary shares [Member] | Restatement Adjustment [Member] | |
Balance Sheet | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | (31,298,000) |
Class A ordinary shares - $0.0001 par value | 313 |
Class A ordinary shares [Member] | As Restated [Member] | |
Balance Sheet | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 186,052,000 |
Class A ordinary shares - $0.0001 par value | 439 |
Class B ordinary shares [Member] | As Previously Reported [Member] | |
Balance Sheet | |
Class B ordinary shares - $0.0001 par value | 575 |
Class B ordinary shares [Member] | Restatement Adjustment [Member] | |
Balance Sheet | |
Class B ordinary shares - $0.0001 par value | |
Class B ordinary shares [Member] | As Restated [Member] | |
Balance Sheet | |
Class B ordinary shares - $0.0001 par value | 575 |
Impact of the Restatement [Member] | As Previously Reported [Member] | |
Balance Sheet | |
Total assets | 231,527,508 |
Total liabilities | 40,475,499 |
Preferred shares - $0.0001 par value | |
Additional paid-in-capital | 18,140,312 |
Accumulated deficit | (13,141,317) |
Total shareholders’ equity | 5,000,009 |
Total liabilities and shareholders’ equity | 231,527,508 |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | |
Balance Sheet | |
Total assets | |
Total liabilities | |
Preferred shares - $0.0001 par value | |
Additional paid-in-capital | (18,140,312) |
Accumulated deficit | (26,356,096) |
Total shareholders’ equity | (44,496,847) |
Total liabilities and shareholders’ equity | |
Impact of the Restatement [Member] | As Restated [Member] | |
Balance Sheet | |
Total assets | 231,527,508 |
Total liabilities | 40,475,499 |
Preferred shares - $0.0001 par value | |
Accumulated deficit | (39,497,413) |
Total shareholders’ equity | (39,496,838) |
Total liabilities and shareholders’ equity | 231,527,508 |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | As Previously Reported [Member] | |
Balance Sheet | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 186,052,000 |
Class A ordinary shares - $0.0001 par value | 439 |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | Restatement Adjustment [Member] | |
Balance Sheet | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 44,496,847 |
Class A ordinary shares - $0.0001 par value | (439) |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | As Restated [Member] | |
Balance Sheet | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 230,548,847 |
Class A ordinary shares - $0.0001 par value | |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | As Previously Reported [Member] | |
Balance Sheet | |
Class B ordinary shares - $0.0001 par value | 575 |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | Restatement Adjustment [Member] | |
Balance Sheet | |
Class B ordinary shares - $0.0001 par value | |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | As Restated [Member] | |
Balance Sheet | |
Class B ordinary shares - $0.0001 par value | $ 575 |
Restatement of Previously Iss_5
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on the balance sheets (Parentheticals) | Dec. 31, 2020$ / shares |
As Previously Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Preference shares, par value | $ 0.0001 |
Restatement Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Preference shares, par value | 0.0001 |
As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Preference shares, par value | 0.0001 |
Class A ordinary shares [Member] | As Previously Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Class A ordinary shares [Member] | Restatement Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Class A ordinary shares [Member] | As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Class B ordinary shares [Member] | As Previously Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Class B ordinary shares [Member] | Restatement Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Class B ordinary shares [Member] | As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Impact of the Restatement [Member] | As Previously Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Preference shares, par value | 0.0001 |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Preference shares, par value | 0.0001 |
Impact of the Restatement [Member] | As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Preference shares, par value | 0.0001 |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | As Previously Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | Restatement Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | As Previously Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | Restatement Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | 0.0001 |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Ordinary shares, par value | $ 0.0001 |
Restatement of Previously Iss_6
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on operating statement | 12 Months Ended |
Dec. 31, 2020USD ($)$ / sharesshares | |
As Previously Reported [Member] | |
Statement of Operations | |
General and administrative expenses | $ 1,400,440 |
Administrative fees - related party | 120,000 |
Loss from operations | (1,520,440) |
Change in fair value of warrant liabilities | |
Offering costs associated with issuance of public and private warrants | |
Net gain from investments held in Trust Account | 548,847 |
Net loss | $ (971,593) |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ / shares | $ 0.02 |
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted (in Shares) | shares | 21,819,737 |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) | $ / shares | $ 0.02 |
Weighted average shares outstanding of non-redeemable ordinary shares, basic and diluted (in Shares) | shares | 6,787,867 |
Basic and diluted net loss per share, non-redeemable ordinary shares (in Dollars per share) | $ / shares | $ (0.22) |
Restatement Adjustment [Member] | |
Statement of Operations | |
General and administrative expenses | $ 1,452,000 |
Administrative fees - related party | |
Loss from operations | (1,452,000) |
Change in fair value of warrant liabilities | (9,906,000) |
Offering costs associated with issuance of public and private warrants | (790,510) |
Net gain from investments held in Trust Account | |
Net loss | $ (12,148,510) |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ / shares | |
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted (in Shares) | shares | (1,857,759) |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) | $ / shares | |
Weighted average shares outstanding of non-redeemable ordinary shares, basic and diluted (in Shares) | shares | 1,720,711 |
Basic and diluted net loss per share, non-redeemable ordinary shares (in Dollars per share) | $ / shares | $ (1.37) |
As Restated [Member] | |
Statement of Operations | |
General and administrative expenses | $ 2,852,440 |
Administrative fees - related party | 120,000 |
Loss from operations | (2,972,440) |
Change in fair value of warrant liabilities | (9,906,000) |
Offering costs associated with issuance of public and private warrants | (790,510) |
Net gain from investments held in Trust Account | 548,847 |
Net loss | $ (13,120,103) |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ / shares | $ 0.02 |
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted (in Shares) | shares | 19,961,978 |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) | $ / shares | $ 0.02 |
Weighted average shares outstanding of non-redeemable ordinary shares, basic and diluted (in Shares) | shares | 8,508,578 |
Basic and diluted net loss per share, non-redeemable ordinary shares (in Dollars per share) | $ / shares | $ (1.59) |
Impact of the Restatement [Member] | As Previously Reported [Member] | |
Statement of Operations | |
Loss from operations | $ (2,972,440) |
Change in fair value of warrant liabilities | (9,906,000) |
Offering costs associated with issuance of public and private warrants | (790,510) |
Net gain from investments held in Trust Account | 548,847 |
Total other expense | (10,147,663) |
Net loss | $ (13,120,103) |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | shares | 19,961,978 |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ / shares | $ 0.02 |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | shares | 8,508,578 |
Basic and diluted net loss per Class B ordinary share (in Dollars per share) | $ / shares | $ (1.59) |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) | $ / shares | $ 0.02 |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | |
Statement of Operations | |
Loss from operations | |
Change in fair value of warrant liabilities | |
Offering costs associated with issuance of public and private warrants | |
Net gain from investments held in Trust Account | |
Total other expense | |
Net loss | |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | shares | 1,341,301 |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ / shares | $ (0.51) |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | shares | (2,813,906) |
Basic and diluted net loss per Class B ordinary share (in Dollars per share) | $ / shares | $ 1.10 |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) | $ / shares | $ (0.51) |
Impact of the Restatement [Member] | As Restated [Member] | |
Statement of Operations | |
Loss from operations | $ (2,972,440) |
Change in fair value of warrant liabilities | (9,906,000) |
Offering costs associated with issuance of public and private warrants | (790,510) |
Net gain from investments held in Trust Account | 548,847 |
Total other expense | (10,147,663) |
Net loss | $ (13,120,103) |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | shares | 21,303,279 |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ / shares | $ (0.49) |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | shares | 5,694,672 |
Basic and diluted net loss per Class B ordinary share (in Dollars per share) | $ / shares | $ (0.49) |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) | $ / shares | $ (0.49) |
Restatement of Previously Iss_7
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity | 12 Months Ended |
Dec. 31, 2020USD ($)shares | |
As Previously Reported [Member] | Additional Paid-in Capital [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | $ 5,992,115 |
Accumulated deficit | |
Balance at December 31, 2020, Amount | 5,992,115 |
As Previously Reported [Member] | Accumulated Deficit [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (992,807) |
Balance at December 31, 2020, Amount | (992,807) |
As Previously Reported [Member] | Total Shareholders’ Equity [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 5,992,241 |
Accumulated deficit | (992,807) |
Balance at December 31, 2020, Amount | 5,000,009 |
Restatement Adjustment [Member] | Additional Paid-in Capital [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 12,148,197 |
Accumulated deficit | |
Balance at December 31, 2020, Amount | 12,148,197 |
Restatement Adjustment [Member] | Accumulated Deficit [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (12,148,510) |
Balance at December 31, 2020, Amount | (12,148,510) |
Restatement Adjustment [Member] | Total Shareholders’ Equity [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 12,148,510 |
Accumulated deficit | (12,148,510) |
Balance at December 31, 2020, Amount | |
As Restated [Member] | Additional Paid-in Capital [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 18,140,312 |
Accumulated deficit | |
Balance at December 31, 2020, Amount | 18,140,312 |
As Restated [Member] | Accumulated Deficit [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (13,141,317) |
Balance at December 31, 2020, Amount | (13,141,317) |
As Restated [Member] | Total Shareholders’ Equity [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 18,140,751 |
Accumulated deficit | (13,141,317) |
Balance at December 31, 2020, Amount | $ 5,000,009 |
Class A ordinary shares [Member] | As Previously Reported [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | 1,265,000 |
Class A ordinary Amount | $ 126 |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 1,265,000 |
Balance at December 31, 2020, Amount | $ 126 |
Class A ordinary shares [Member] | Restatement Adjustment [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | 3,129,800 |
Class A ordinary Amount | $ 313 |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 3,129,800 |
Balance at December 31, 2020, Amount | $ 313 |
Class A ordinary shares [Member] | As Restated [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | 4,394,800 |
Class A ordinary Amount | $ 439 |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 4,394,800 |
Balance at December 31, 2020, Amount | $ 439 |
Class B ordinary shares [Member] | As Previously Reported [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 5,750,000 |
Balance at December 31, 2020, Amount | $ 575 |
Class B ordinary shares [Member] | Restatement Adjustment [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | |
Balance at December 31, 2020, Amount | |
Class B ordinary shares [Member] | As Restated [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 5,750,000 |
Balance at December 31, 2020, Amount | $ 575 |
Impact of the Restatement [Member] | As Previously Reported [Member] | Additional Paid-in Capital [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 18,140,312 |
Accumulated deficit | |
Balance at December 31, 2020, Amount | 18,140,312 |
Impact of the Restatement [Member] | As Previously Reported [Member] | Accumulated Deficit [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (13,141,317) |
Balance at December 31, 2020, Amount | (13,141,317) |
Impact of the Restatement [Member] | As Previously Reported [Member] | Total Shareholders’ Equity [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | 18,140,751 |
Accumulated deficit | (13,141,317) |
Balance at December 31, 2020, Amount | 5,000,009 |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | Additional Paid-in Capital [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | (18,140,312) |
Accumulated deficit | |
Balance at December 31, 2020, Amount | (18,140,312) |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | Accumulated Deficit [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (26,356,096) |
Balance at December 31, 2020, Amount | (26,356,096) |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | Total Shareholders’ Equity [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | (18,140,751) |
Accumulated deficit | (26,356,096) |
Balance at December 31, 2020, Amount | (44,496,847) |
Impact of the Restatement [Member] | As Restated [Member] | Additional Paid-in Capital [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Amount | |
Impact of the Restatement [Member] | As Restated [Member] | Accumulated Deficit [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (39,497,413) |
Balance at December 31, 2020, Amount | (39,497,413) |
Impact of the Restatement [Member] | As Restated [Member] | Total Shareholders’ Equity [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary Amount | |
Accumulated deficit | (39,497,413) |
Balance at December 31, 2020, Amount | $ (39,496,838) |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | As Previously Reported [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | 4,394,800 |
Class A ordinary Amount | $ 439 |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 4,394,800 |
Balance at December 31, 2020, Amount | $ 439 |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | Restatement Adjustment [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | (4,394,800) |
Class A ordinary Amount | $ (439) |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | (4,394,800) |
Balance at December 31, 2020, Amount | $ (439) |
Impact of the Restatement [Member] | Class A ordinary shares [Member] | As Restated [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | |
Balance at December 31, 2020, Amount | |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | As Previously Reported [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 5,750,000 |
Balance at December 31, 2020, Amount | $ 575 |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | Restatement Adjustment [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | |
Balance at December 31, 2020, Amount | |
Impact of the Restatement [Member] | Class B ordinary shares [Member] | As Restated [Member] | |
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on statement of shareholders’ equity [Line Items] | |
Class A ordinary shares (in Shares) | shares | |
Class A ordinary Amount | |
Accumulated deficit | |
Balance at December 31, 2020, Shares (in Shares) | shares | 5,750,000 |
Balance at December 31, 2020, Amount | $ 575 |
Restatement of Previously Iss_8
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on cashflow statement | 12 Months Ended |
Dec. 31, 2020USD ($) | |
As Previously Reported [Member] | |
Statement of Cash Flows | |
Net loss | $ (971,593) |
Change in fair value of warrant liabilities | |
Share based compensation | |
Offering costs associated with issuance of public and private warrants | |
Net cash used in operating activities | (447,364) |
Net cash used in investing activities | (230,000,000) |
Net cash provided by financing activities | 231,339,602 |
Net change in cash | 892,238 |
Restatement Adjustment [Member] | |
Statement of Cash Flows | |
Net loss | (12,148,510) |
Change in fair value of warrant liabilities | 9,906,000 |
Share based compensation | 1,452,000 |
Offering costs associated with issuance of public and private warrants | (790,510) |
Net cash used in operating activities | |
Net cash used in investing activities | |
Net cash provided by financing activities | |
Net change in cash | |
As Restated [Member] | |
Statement of Cash Flows | |
Net loss | (13,120,103) |
Change in fair value of warrant liabilities | 9,906,000 |
Share based compensation | 1,452,000 |
Offering costs associated with issuance of public and private warrants | (790,510) |
Net cash used in operating activities | (447,364) |
Net cash used in investing activities | (230,000,000) |
Net cash provided by financing activities | 231,339,602 |
Net change in cash | 892,238 |
Impact of the Restatement [Member] | As Previously Reported [Member] | |
Statement of Cash Flows | |
Net loss | (13,120,103) |
Statement of Cash Flows - Supplemental disclosure of noncash activities: | |
Initial value of Class A ordinary shares subject to possible redemption | 196,927,450 |
Change in fair value of Class A ordinary shares subject to possible redemption | (10,875,450) |
Accretion of Class A ordinary shares subject to redemption amount | |
Impact of the Restatement [Member] | Restatement Adjustment [Member] | |
Statement of Cash Flows | |
Net loss | |
Statement of Cash Flows - Supplemental disclosure of noncash activities: | |
Initial value of Class A ordinary shares subject to possible redemption | (196,927,450) |
Change in fair value of Class A ordinary shares subject to possible redemption | 10,875,450 |
Accretion of Class A ordinary shares subject to redemption amount | 26,380,521 |
Impact of the Restatement [Member] | As Restated [Member] | |
Statement of Cash Flows | |
Net loss | (13,120,103) |
Statement of Cash Flows - Supplemental disclosure of noncash activities: | |
Initial value of Class A ordinary shares subject to possible redemption | |
Change in fair value of Class A ordinary shares subject to possible redemption | |
Accretion of Class A ordinary shares subject to redemption amount | $ 26,380,521 |
Basis of Presentation and Sum_3
Basis of Presentation and Summary of Significant Accounting Policies (Details) | 12 Months Ended |
Dec. 31, 2020USD ($)shares | |
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items] | |
Federal depository insurance coverage (in Dollars) | $ | $ 250,000 |
Maturity term | 185 years |
Effect of warrants sold in initial public offering and private placement to purchase shares of common stock | 18,100,000 |
Derivative warrant liabilities (in Dollars) | $ | $ (6,600,000) |
Initial Public Offering [Member] | |
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items] | |
Ordinary shares warrants issued | 11,500,000 |
Initial Public Offering [Member] | Warrant [Member] | |
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items] | |
Ordinary shares warrants issued | 18,100,000 |
Basis of Presentation and Sum_4
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per ordinary share - USD ($) | 2 Months Ended | 12 Months Ended |
Dec. 31, 2019 | Dec. 31, 2020 | |
Class A | ||
Numerator: | ||
Allocation of net loss | $ (10,352,682) | |
Denominator: | ||
Weighted average ordinary shares outstanding, basic and diluted | 21,303,279 | |
Basic and diluted net loss per ordinary share | $ (0.49) | |
Class B | ||
Numerator: | ||
Allocation of net loss | $ (21,214) | $ (2,767,421) |
Denominator: | ||
Weighted average ordinary shares outstanding, basic and diluted | 5,000,000 | 5,694,672 |
Basic and diluted net loss per ordinary share | $ 0 | $ (0.49) |
Initial Public Offering (Detail
Initial Public Offering (Details) | 1 Months Ended |
Jan. 28, 2020$ / sharesshares | |
Initial Public Offering (Details) [Line Items] | |
Redeemable warrant, description | Each Unit consists of one Class A ordinary share, and one-half of one Public Warrant. Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (Note 6). |
Initial Public Offering [Member] | |
Initial Public Offering (Details) [Line Items] | |
Sale of units | 23,000,000 |
Unit price (in Dollars per share) | $ / shares | $ 10 |
Over-Allotment Option [Member] | |
Initial Public Offering (Details) [Line Items] | |
Sale of units | 3,000,000 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | Nov. 30, 2019 | Dec. 31, 2019 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Jan. 28, 2020 | Nov. 19, 2019 |
Related Party Transactions (Details) [Line Items] | ||||||||
Ordinary shares equals or exceeds price per share (in Dollars per share) | $ 10.30 | $ 10 | $ 9.96 | $ 9.50 | $ 9.42 | |||
Gross proceeds | $ 6,600,000 | |||||||
Aggregate loan | $ 300,000 | |||||||
Payables to related party | $ 139,000 | |||||||
Working Capital Loans | 1,500,000 | |||||||
Administrative and support services | 10,000 | |||||||
Company incurred expenses | 120,000 | |||||||
Accrued expenses | $ 120,000 | |||||||
Private Placement Warrants [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Aggregate shares (in Shares) | 6,600,000 | |||||||
Price per warrant (in Dollars per share) | $ 1 | |||||||
Gross proceeds | $ 6,600,000 | |||||||
Deferred offering costs | $ 21,000 | |||||||
Class B ordinary shares [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||||
Class A ordinary share [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Par value (in Dollars per share) | $ 0.0001 | 0.0001 | ||||||
Class A ordinary share [Member] | Private Placement Warrants [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Share price (in Dollars per share) | 11.50 | |||||||
Series of Individually Immaterial Business Acquisitions [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Business Combination entity price per warrant (in Dollars per share) | $ 1 | |||||||
Founder Shares [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Par value (in Dollars per share) | $ 0.0001 | |||||||
Aggregate price | $ 25,000 | |||||||
Transferred an aggregate Shares (in Shares) | 1,092,500 | |||||||
Forfeit an aggregate shares (in Shares) | 750,000 | |||||||
Founder Shares [Member] | Class B ordinary shares [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Stock issued (in Shares) | 5,750,000 | |||||||
Founder Shares [Member] | Class A ordinary share [Member] | ||||||||
Related Party Transactions (Details) [Line Items] | ||||||||
Ordinary shares equals or exceeds price per share (in Dollars per share) | $ 12 |
Commitments and Contingencies (
Commitments and Contingencies (Details) $ / shares in Units, $ in Millions | 12 Months Ended |
Dec. 31, 2020USD ($)$ / shares | |
Commitments and Contingencies (Details) [Line Items] | |
Underwriting agreement, description | The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. |
Underwriting discount | $ / shares | $ 0.35 |
Underwriting discount amount | $ | $ 8.1 |
Initial Public Offering [Member] | |
Commitments and Contingencies (Details) [Line Items] | |
Underwriting discount | $ / shares | $ 0.20 |
Underwriting discount amount | $ | $ 4.6 |
Derivative Warrant Liabilities
Derivative Warrant Liabilities (Details) | 12 Months Ended |
Dec. 31, 2020$ / shares | |
Derivative Warrant Liabilities (Details) [Line Items] | |
Warrant expire term | 5 years |
Business combination effective issue price per share | $ 9.20 |
Equity proceeds percentage | 60.00% |
Exercise price warrants percentage | 115.00% |
Redemption trigger price per share | $ 18 |
Market value percentage | 180.00% |
Warrant description | The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per Warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of the Class A ordinary share equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders. |
Business Acquisitions [Member] | |
Derivative Warrant Liabilities (Details) [Line Items] | |
Business combination price per share | $ 1 |
Business Acquisitions [Member] | Warrant [Member] | |
Derivative Warrant Liabilities (Details) [Line Items] | |
Business combination price per share | $ 9.20 |
Class A Ordinary Shares Subje_3
Class A Ordinary Shares Subject to Possible Redemption (Restated) (Details) - Class A ordinary shares [Member] - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Class A Ordinary Shares Subject to Possible Redemption (Restated) (Details) [Line Items] | ||
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, subject to possible redemption | 23,000,000 |
Class A Ordinary Shares Subje_4
Class A Ordinary Shares Subject to Possible Redemption (Restated) (Details) - Schedule of class A ordinary shares reflected on the balance sheet | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Schedule of class A ordinary shares reflected on the balance sheet [Abstract] | |
Gross proceeds received from Initial Public Offering | $ 230,000,000 |
Less: | |
Fair value of Public Warrants at issuance | (13,340,000) |
Offering costs allocated to Class A ordinary shares | (12,491,674) |
Plus: | |
Accretion on Class A ordinary shares to redemption value | 26,380,521 |
Class A ordinary shares subject to possible redemption | $ 230,548,847 |
Shareholders' Equity (Details)
Shareholders' Equity (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Shareholders' Equity (Details) [Line Items] | ||
Preferred stock shares authorized | 1,000,000 | 1,000,000 |
Preferred stock shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Class A ordinary shares [Member] | ||
Shareholders' Equity (Details) [Line Items] | ||
Ordinary shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares issued | 0 | |
Ordinary shares outstanding | 23,000,000 | 0 |
Class B ordinary shares [Member] | ||
Shareholders' Equity (Details) [Line Items] | ||
Ordinary shares authorized | 20,000,000 | 20,000,000 |
Ordinary shares par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares outstanding | 5,750,000 | 5,750,000 |
Shares subject to forfeiture | 750,000 | |
Issued and outstanding percentage | 20.00% |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Jan. 28, 2020 |
Fair Value Disclosures [Abstract] | ||
Derivative warrant liabilities | $ 9.9 | $ 21.4 |
Fair Value Measurements (Deta_2
Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Assets | |
Investments held in Trust Account - money market fund | $ 230,548,847 |
Liabilities: | |
Warrant liabilities - public warrants (restated) | 19,550,000 |
Warrant liabilities - private warrants (restated) | 11,748,000 |
Level 1 [Member] | |
Assets | |
Investments held in Trust Account - money market fund | 230,548,847 |
Liabilities: | |
Warrant liabilities - public warrants (restated) | 19,550,000 |
Warrant liabilities - private warrants (restated) | |
Level 2 [Member] | |
Assets | |
Investments held in Trust Account - money market fund | |
Liabilities: | |
Warrant liabilities - public warrants (restated) | |
Warrant liabilities - private warrants (restated) | |
Level 3 [Member] | |
Assets | |
Investments held in Trust Account - money market fund | |
Liabilities: | |
Warrant liabilities - public warrants (restated) | |
Warrant liabilities - private warrants (restated) | $ 11,748,000 |
Fair Value Measurements (Deta_3
Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities - USD ($) | 2 Months Ended | 12 Months Ended |
Dec. 31, 2019 | Dec. 31, 2020 | |
Schedule of change in the fair value of the derivative warrant liabilities [Abstract] | ||
Warrant liabilities at January 1, 2020 | ||
Issuance of public and private warrants | 21,392,000 | |
Change in fair value of warrant liabilities | 9,906,000 | |
Warrant liabilities at December 31, 2020 | $ 31,298,000 |
Fair Value Measurements (Deta_4
Fair Value Measurements (Details) - Schedule of information regarding Level 3 fair value measurements inputs - $ / shares | 3 Months Ended | ||||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Jan. 28, 2020 | |
Schedule of information regarding Level 3 fair value measurements inputs [Abstract] | |||||
Exercise price (in Dollars per share) | $ 11.50 | $ 11.50 | $ 11.50 | $ 11.50 | $ 11.50 |
Stock Price (in Dollars per share) | $ 10.30 | $ 10 | $ 9.96 | $ 9.50 | $ 9.42 |
Term (in years) | 5 years 211 days | 5 years 302 days | 6 years 29 days | 6 years 120 days | 6 years 6 months |
Volatility | 24.50% | 23.10% | 16.90% | 10.50% | 18.40% |
Risk-free interest rate | 0.44% | 0.36% | 0.40% | 0.49% | 1.54% |
Dividend yield |
Quarterly Financial Informati_3
Quarterly Financial Information (Unaudited) (Details) - Schedule of balance sheet - Parent [Member] - USD ($) | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 |
As Previously Reported [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Total Assets | $ 231,600,223 | $ 231,677,875 | $ 231,737,329 |
Total liabilities | 35,676,701 | 26,947,235 | 15,543,013 |
Shareholders’ equity (deficit) | |||
Preferred shares - $0.0001 par value | |||
Additional paid-in-capital | 13,268,841 | 4,461,807 | (7,001,747) |
Accumulated deficit | (8,269,804) | 537,314 | 12,000,990 |
Total shareholders’ equity (deficit) | 5,000,007 | 5,000,003 | 5,000,006 |
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) | 231,600,223 | 231,677,875 | 231,737,329 |
Restatement Adjustment [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Total Assets | |||
Total liabilities | |||
Shareholders’ equity (deficit) | |||
Preferred shares - $0.0001 par value | |||
Additional paid-in-capital | (13,268,841) | (4,461,807) | 7,001,747 |
Accumulated deficit | (26,351,790) | (26,330,937) | (26,090,196) |
Total shareholders’ equity (deficit) | (39,621,026) | (30,793,051) | (19,088,637) |
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) | |||
As Restated [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Total Assets | 231,600,223 | 231,677,875 | 231,737,329 |
Total liabilities | 35,676,701 | 26,947,235 | 15,543,013 |
Shareholders’ equity (deficit) | |||
Preferred shares - $0.0001 par value | |||
Additional paid-in-capital | |||
Accumulated deficit | (34,621,594) | (25,793,623) | (14,089,206) |
Total shareholders’ equity (deficit) | (34,621,019) | (25,793,048) | (14,088,631) |
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit) | 231,600,223 | 231,677,875 | 231,737,329 |
Class A ordinary shares [Member] | As Previously Reported [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 190,923,515 | 199,730,637 | 211,194,310 |
Shareholders’ equity (deficit) | |||
Ordinary shares - $0.0001 par value | 395 | 307 | 188 |
Class A ordinary shares [Member] | Restatement Adjustment [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 39,621,026 | 30,793,051 | 19,088,637 |
Shareholders’ equity (deficit) | |||
Ordinary shares - $0.0001 par value | (395) | (307) | (188) |
Class A ordinary shares [Member] | As Restated [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption | 230,544,541 | 230,523,688 | 230,282,947 |
Shareholders’ equity (deficit) | |||
Ordinary shares - $0.0001 par value | |||
Class B ordinary shares [Member] | As Previously Reported [Member] | |||
Shareholders’ equity (deficit) | |||
Ordinary shares - $0.0001 par value | 575 | 575 | 575 |
Class B ordinary shares [Member] | Restatement Adjustment [Member] | |||
Shareholders’ equity (deficit) | |||
Ordinary shares - $0.0001 par value | |||
Class B ordinary shares [Member] | As Restated [Member] | |||
Shareholders’ equity (deficit) | |||
Ordinary shares - $0.0001 par value | $ 575 | $ 575 | $ 575 |
Quarterly Financial Informati_4
Quarterly Financial Information (Unaudited) (Details) - Schedule of balance sheet (Parentheticals) - Parent [Member] - $ / shares | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 |
As Previously Reported [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Preferred shares, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Restatement Adjustment [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Preferred shares, par value | 0.0001 | 0.0001 | 0.0001 |
As Restated [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Preferred shares, par value | 0.0001 | 0.0001 | 0.0001 |
Class A ordinary shares [Member] | As Previously Reported [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Ordinary shares, shares subject to possible redemption par value | 0.0001 | 0.0001 | 0.0001 |
Ordinary shares, par value | 0.0001 | 0.0001 | 0.0001 |
Class A ordinary shares [Member] | Restatement Adjustment [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Ordinary shares, shares subject to possible redemption par value | 0.0001 | 0.0001 | 0.0001 |
Ordinary shares, par value | 0.0001 | 0.0001 | 0.0001 |
Class A ordinary shares [Member] | As Restated [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Ordinary shares, shares subject to possible redemption par value | 0.0001 | 0.0001 | 0.0001 |
Ordinary shares, par value | 0.0001 | 0.0001 | 0.0001 |
Class B ordinary shares [Member] | As Previously Reported [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Ordinary shares, par value | 0.0001 | 0.0001 | 0.0001 |
Class B ordinary shares [Member] | Restatement Adjustment [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Ordinary shares, par value | 0.0001 | 0.0001 | 0.0001 |
Class B ordinary shares [Member] | As Restated [Member] | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Ordinary shares, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Quarterly Financial Informati_5
Quarterly Financial Information (Unaudited) (Details) - Schedule of operation statement - Parent [Member] - USD ($) | 3 Months Ended | 6 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Jun. 30, 2020 | Sep. 30, 2020 | |
As Previously Reported [Member] | |||||
Condensed Income Statements, Captions [Line Items] | |||||
Loss from operations | $ (171,971) | $ (120,417) | $ (1,622,233) | $ (1,742,650) | $ (1,914,621) |
Other (expense) income: | |||||
Change in fair value of warrant liabilities | (8,656,000) | (11,584,000) | 14,152,000 | 2,568,000 | (6,088,000) |
Offering costs associated with issuance of public and private warrants | (790,510) | (790,510) | (790,510) | ||
Net gain from investments held in Trust Account | 20,853 | 240,741 | 282,947 | 523,688 | 544,541 |
Total other (expense) income | (8,635,147) | (11,343,259) | 13,644,437 | 2,301,178 | (6,333,969) |
Net income (loss) | $ (8,807,118) | $ (11,463,676) | $ 12,022,204 | $ 558,528 | $ (8,248,590) |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | 19,919,867 | 21,106,354 | 19,715,037 | 17,485,937 | 18,303,169 |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ 0 | $ 0.01 | $ 0.01 | $ 0.03 | $ 0.02 |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | 8,830,133 | 7,643,646 | 7,837,776 | 7,740,711 | 8,106,502 |
Basic and diluted net income per Class B ordinary share (in Dollars per share) | $ (1) | $ (1.53) | $ 1.50 | $ 0.01 | $ (1.07) |
Restatement Adjustment [Member] | |||||
Condensed Income Statements, Captions [Line Items] | |||||
Loss from operations | |||||
Other (expense) income: | |||||
Change in fair value of warrant liabilities | |||||
Offering costs associated with issuance of public and private warrants | |||||
Net gain from investments held in Trust Account | |||||
Total other (expense) income | |||||
Net income (loss) | |||||
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | 3,080,133 | 1,893,646 | (3,539,213) | 2,101,975 | 2,430,407 |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ (0.31) | $ (0.41) | $ 0.54 | $ (0.01) | $ (0.33) |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | (3,080,133) | (1,893,646) | (2,310,304) | (2,101,975) | (2,430,407) |
Basic and diluted net income per Class B ordinary share (in Dollars per share) | $ 0.69 | $ 1.13 | $ (0.95) | $ 0.01 | $ 0.76 |
As Restated [Member] | |||||
Condensed Income Statements, Captions [Line Items] | |||||
Loss from operations | $ (171,971) | $ (120,417) | $ (1,622,233) | $ (1,742,650) | $ (1,914,621) |
Other (expense) income: | |||||
Change in fair value of warrant liabilities | (8,656,000) | (11,584,000) | 14,152,000 | 2,568,000 | (6,088,000) |
Offering costs associated with issuance of public and private warrants | (790,510) | (790,510) | (790,510) | ||
Net gain from investments held in Trust Account | 20,853 | 240,741 | 282,947 | 523,688 | 544,541 |
Total other (expense) income | (8,635,147) | (11,343,259) | 13,644,437 | 2,301,178 | (6,333,969) |
Net income (loss) | $ (8,807,118) | $ (11,463,676) | $ 12,022,204 | $ 558,528 | $ (8,248,590) |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted (in Shares) | 23,000,000 | 23,000,000 | 16,175,824 | 19,587,912 | 20,733,577 |
Basic and diluted net income (loss) per Class A ordinary share (in Dollars per share) | $ (0.31) | $ (0.40) | $ 0.55 | $ 0.02 | $ (0.31) |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted (in Shares) | 5,750,000 | 5,750,000 | 5,527,473 | 5,638,736 | 5,676,095 |
Basic and diluted net income per Class B ordinary share (in Dollars per share) | $ (0.31) | $ (0.40) | $ 0.55 | $ 0.02 | $ (0.31) |
Quarterly Financial Informati_6
Quarterly Financial Information (Unaudited) (Details) - Schedule of statement of cash flows - USD ($) | 3 Months Ended | 6 Months Ended | 9 Months Ended |
Mar. 31, 2020 | Jun. 30, 2020 | Sep. 30, 2020 | |
As Previously Reported [Member] | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Initial value of Class A ordinary shares subject to possible redemption | $ 196,927,450 | $ 196,927,450 | $ 196,927,450 |
Change in fair value of Class A ordinary shares subject to possible redemption | 14,266,860 | 2,803,187 | (6,003,935) |
Accretion of Class A ordinary shares subject to redemption amount | |||
Restatement Adjustment [Member] | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Initial value of Class A ordinary shares subject to possible redemption | (196,927,450) | (196,927,450) | (196,927,450) |
Change in fair value of Class A ordinary shares subject to possible redemption | (14,266,860) | (2,803,187) | 6,003,935 |
Accretion of Class A ordinary shares subject to redemption amount | 26,114,621 | 26,355,362 | 26,376,215 |
As Restated [Member] | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Initial value of Class A ordinary shares subject to possible redemption | |||
Change in fair value of Class A ordinary shares subject to possible redemption | |||
Accretion of Class A ordinary shares subject to redemption amount | $ 26,114,621 | $ 26,355,362 | $ 26,376,215 |
Quarterly Financial Informati_7
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity - USD ($) | 3 Months Ended | 6 Months Ended | 9 Months Ended | |||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Jun. 30, 2020 | Sep. 30, 2020 | |
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance | $ 3,786 | |||||
Accretion on Class A ordinary shares subject to possible redemption amount (in Shares) | (4,306) | (20,853) | (240,741) | (26,114,621) | ||
Net income (Loss) | $ (4,871,513) | $ (8,807,118) | $ (11,463,676) | $ 12,022,204 | ||
Balance | (34,621,019) | (25,793,048) | (14,088,631) | |||
Balance as restated | (39,496,838) | |||||
As Previously Reported [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as previously reported | 5,000,006 | $ 5,000,003 | $ 5,000,007 | |||
restatement adjustment [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance restatement adjustment | (19,088,637) | (30,793,051) | (39,621,026) | |||
As Restated [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as restated | (14,088,631) | (25,793,048) | (34,621,019) | |||
Additional Paid-in Capital [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance | $ 24,425 | |||||
Accretion on Class A ordinary shares subject to possible redemption amount (in Shares) | (24,425) | |||||
Net income (Loss) | ||||||
Balance | ||||||
Balance as restated | ||||||
Additional Paid-in Capital [Member] | As Previously Reported [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as previously reported | (7,001,747) | 4,461,807 | 13,268,841 | |||
Additional Paid-in Capital [Member] | restatement adjustment [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance restatement adjustment | 7,001,747 | (4,461,807) | (13,268,841) | |||
Additional Paid-in Capital [Member] | As Restated [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as restated | ||||||
Retained Earnings (Accumulated Deficit) [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance | $ (21,214) | |||||
Accretion on Class A ordinary shares subject to possible redemption amount (in Shares) | (4,306) | (20,853) | (240,741) | (26,090,196) | ||
Net income (Loss) | $ (4,871,513) | $ (8,807,118) | $ (11,463,676) | $ 12,022,204 | ||
Balance | (34,621,594) | (25,793,623) | (14,089,206) | |||
Balance as restated | $ (39,497,413) | |||||
Retained Earnings (Accumulated Deficit) [Member] | As Previously Reported [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as previously reported | 12,000,990 | 537,314 | (8,269,804) | |||
Retained Earnings (Accumulated Deficit) [Member] | restatement adjustment [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance restatement adjustment | (26,090,196) | (26,330,937) | (26,351,790) | |||
Retained Earnings (Accumulated Deficit) [Member] | As Restated [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as restated | $ (14,089,206) | $ (25,793,623) | $ (34,621,594) | |||
Class A ordinary share [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance (in Shares) | ||||||
Balance | ||||||
Accretion on Class A ordinary shares subject to possible redemption amount (in Shares) | ||||||
Net income (Loss) | ||||||
Balance (in Shares) | ||||||
Balance | ||||||
Balance as restated (in Shares) | ||||||
Balance as restated | ||||||
Class A ordinary share [Member] | As Previously Reported [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as previously reported (in Shares) | 1,880,569 | 3,070,560 | 3,951,242 | |||
Balance as previously reported | $ 188 | $ 307 | $ 395 | |||
Class A ordinary share [Member] | restatement adjustment [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance restatement adjustment (in Shares) | (1,880,569) | (3,070,560) | (3,951,242) | |||
Balance restatement adjustment | $ (188) | $ (307) | $ (395) | |||
Class A ordinary share [Member] | As Restated [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as restated (in Shares) | ||||||
Balance as restated | ||||||
Class B ordinary shares [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance (in Shares) | 5,750,000 | |||||
Balance | $ 575 | |||||
Accretion on Class A ordinary shares subject to possible redemption amount (in Shares) | ||||||
Net income (Loss) | ||||||
Balance (in Shares) | 5,750,000 | 5,750,000 | 5,750,000 | |||
Balance | $ 575 | $ 575 | $ 575 | |||
Balance as restated (in Shares) | 5,750,000 | |||||
Balance as restated | $ 575 | |||||
Class B ordinary shares [Member] | As Previously Reported [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as previously reported (in Shares) | 5,750,000 | 5,750,000 | 5,750,000 | |||
Balance as previously reported | $ 575 | $ 575 | $ 575 | |||
Class B ordinary shares [Member] | restatement adjustment [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance restatement adjustment (in Shares) | ||||||
Balance restatement adjustment | ||||||
Class B ordinary shares [Member] | As Restated [Member] | ||||||
Quarterly Financial Information (Unaudited) (Details) - Schedule of stockholders equity [Line Items] | ||||||
Balance as restated (in Shares) | 5,750,000 | 5,750,000 | 5,750,000 | |||
Balance as restated | $ 575 | $ 575 | $ 575 |